Caroline Litchfield - Merck Ex CFO
MRK Stock | EUR 120.00 2.40 0.34% |
Insider
Caroline Litchfield is Ex CFO of Merck Company
Age | 54 |
Phone | 908 740 4000 |
Web | https://www.merck.com |
Merck Management Efficiency
The company has return on total asset (ROA) of 0.1268 % which means that it generated a profit of $0.1268 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.351 %, meaning that it generated $0.351 on every $100 dollars invested by stockholders. Merck's management efficiency ratios could be used to measure how well Merck manages its routine affairs as well as how well it operates its assets and liabilities.Merck Company has accumulated 27.59 B in total debt with debt to equity ratio (D/E) of 99.4, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Merck Company has a current ratio of 1.19, suggesting that it may not be capable to disburse its financial obligations in time and when they become due. Debt can assist Merck until it has trouble settling it off, either with new capital or with free cash flow. So, Merck's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Merck Company sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Merck to invest in growth at high rates of return. When we think about Merck's use of debt, we should always consider it together with cash and equity.
Similar Executives
Showing other executives | INSIDER Age | ||
Herta Stockbauer | BKS Bank AG | 63 | |
Norbert Brger | AMAG Austria Metall | N/A | |
Herbert Juranek | Addiko Bank AG | 57 | |
Klaus Patterer | BKS Bank AG | N/A | |
Leopold Pocksteiner | AMAG Austria Metall | N/A | |
Engineer Knapp | UNIQA Insurance Group | 40 | |
Tadej Krasovec | Addiko Bank AG | N/A | |
Edgar Flaggl | Addiko Bank AG | N/A | |
Anton Eberle | AMAG Austria Metall | N/A | |
Magistrate Mayer | AMAG Austria Metall | 52 | |
Magistrate Knig | BKS Bank AG | N/A | |
Magistrate Cuder | BKS Bank AG | N/A | |
Magistrate Kranitzer | BKS Bank AG | 64 | |
Dieter Kohl | BKS Bank AG | N/A | |
Magistrate Gerlach | UNIQA Insurance Group | 44 | |
Csongor Nemeth | Addiko Bank AG | N/A | |
Michael Oplustil | UNIQA Insurance Group | N/A | |
Magistrate Novak | BKS Bank AG | 52 | |
Victor MBA | AMAG Austria Metall | 48 | |
Michaela Gerschpacher | Oberbank AG | N/A | |
Ronald Hassler | BKS Bank AG | N/A |
Management Performance
Return On Equity | 0.35 | |||
Return On Asset | 0.13 |
Merck Company Leadership Team
Elected by the shareholders, the Merck's board of directors comprises two types of representatives: Merck inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Merck. The board's role is to monitor Merck's management team and ensure that shareholders' interests are well served. Merck's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Merck's outside directors are responsible for providing unbiased perspectives on the board's policies.
Cristal Downing, Ex Officer | ||
Jennifer Zachary, General Counsel | ||
David Williams, Ex Officer | ||
Caroline Litchfield, Ex CFO | ||
Lisa LeCointeCephas, VP Officer | ||
Richard DeLuca, Executive Vice President and Presidentident - Merck Animal Health | ||
Kenneth Frazier, Chairman of the Board and Presidentident, CEO | ||
Peter Dannenbaum, VP Relations | ||
Jennifer Mauer, VP Communications | ||
Robert JD, Pres Chairman |
Merck Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Merck a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.35 | |||
Return On Asset | 0.13 | |||
Profit Margin | 0.24 % | |||
Operating Margin | 0.38 % | |||
Current Valuation | 286.52 B | |||
Shares Outstanding | 2.54 B | |||
Shares Owned By Insiders | 0.10 % | |||
Shares Owned By Institutions | 76.37 % | |||
Price To Earning | 21.59 X | |||
Price To Book | 6.31 X |
Currently Active Assets on Macroaxis
INJ | Injective | |
PENDLE | Pendle | |
NVDA | NVIDIA | |
GOLD | Barrick Gold Corp | |
GE | GE Aerospace |
Additional Information and Resources on Investing in Merck Stock
When determining whether Merck Company is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Merck Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Merck Company Stock. Highlighted below are key reports to facilitate an investment decision about Merck Company Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merck Company. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as various price indices. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.